Advertisement
UK markets close in 5 hours 53 minutes
  • FTSE 100

    8,246.80
    -6.11 (-0.07%)
     
  • FTSE 250

    21,218.12
    +15.23 (+0.07%)
     
  • AIM

    785.66
    -0.51 (-0.06%)
     
  • GBP/EUR

    1.1903
    -0.0000 (-0.00%)
     
  • GBP/USD

    1.2988
    -0.0002 (-0.02%)
     
  • Bitcoin GBP

    48,321.73
    +1,851.65 (+3.98%)
     
  • CMC Crypto 200

    1,304.67
    +35.72 (+2.82%)
     
  • S&P 500

    5,615.35
    +30.81 (+0.55%)
     
  • DOW

    40,000.90
    +247.10 (+0.62%)
     
  • CRUDE OIL

    82.43
    +0.22 (+0.27%)
     
  • GOLD FUTURES

    2,414.30
    -6.40 (-0.26%)
     
  • NIKKEI 225

    41,190.68
    -1,033.32 (-2.45%)
     
  • HANG SENG

    18,015.94
    -277.44 (-1.52%)
     
  • DAX

    18,722.26
    -25.92 (-0.14%)
     
  • CAC 40

    7,707.06
    -17.26 (-0.22%)
     

Zacks Industry Outlook Highlights Mettler-Toledo International and Waters

For Immediate Release

Chicago, IL – March 28, 2023 – Today, Zacks Equity Research discusses Mettler-Toledo International MTD and Waters WAT.

Industry: Scientific Instruments

Link: https://www.zacks.com/commentary/2070962/2-instruments-stocks-to-watch-from-a-challenging-industry

The Zacks Instruments - Scientific industry is suffering from challenging macroeconomic conditions globally, including tighter monetary policies, higher inflation and raging interest rates to combat inflation, the Russia-Ukraine war and lingering COVID-led disruptions in China. However, industry participants — Mettler-Toledo International and Waters — are gaining from growing testing needs of newer biological drugs, ever-increasing complexity in molecular structure and rising instrument orders across the globe.

ADVERTISEMENT

Increasing healthcare spending is another key catalyst, driven by aging demography, and continued innovation in the pharma and life sciences end-markets. Higher demand for generic drugs and biosimilars drives growth for scientific tool and apparatus providers.

Industry Description

The Zacks Instruments - Scientific industry comprises companies offering scientific instruments, analytical tools, diagnostic solutions, precision instruments & services, and test & sensor solutions. The primary end markets served by the industry participants are life science research in academia, medical schools and government, pharmaceuticals and biotechnology, microbiology and diagnostics, nanotechnology, and materials science research.

A few companies also serve the food and nutritional safety, biochemical, and industrial spaces. Most industry participants are under stringent regulatory scrutiny worldwide. They have to adhere to the U.S. Food and Drug Administration (FDA) norms, as well as rules set by other global regulatory bodies, for serving highly regulated end-markets like life sciences and pharma.

3 Trends Shaping the Instruments-Scientific Industry's Future

End-Market Demand Strong: The industry is benefiting from strong end-market demand, particularly from the life science, pharmaceutical and academic markets. Increasing demand for generic drugs and biosimilars is driving growth for scientific tool and apparatus providers. Pharma companies are focused on rapidly growing areas like proteomics and phenomics, biopharma and applied, microbiology and diagnostics, and neuroscience and cell microscopy. This creates significant demand for the instruments provided by industry participants.

Aging Demography Driving Spending: Socioeconomic factors like aging demography and increasing environmental regulations are fueling the demand for scientific measurement solutions. Robust worldwide healthcare spending is another major growth driver.

Emerging Market Prospects Solid: The industry is gaining from increasing exposure to developing economies like China and India. Prospects in China are huge as regulators attempt to raise the country’s biopharma industry to global standards. Efforts to improve the country’s drug development process and production quality are noteworthy. These factors result in strong demand for instruments.

Zacks Industry Rank Indicates Dim Prospects

The Zacks Instruments - Scientific industry is housed within the broader Zacks Computer and Technology sector. It carries a Zacks Industry Rank #172, which places it at the bottom 31% of more than 250 Zacks industries.

The group’s Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates dim near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperforms the bottom 50% by a factor of more than 2 to 1.

The industry’s positioning in the bottom 50% of the Zacks-ranked industries is a result of a negative earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, analysts are pessimistic about this group’s earnings growth potential. Since Mar 31, 2022, the industry’s 2023 earnings estimates have moved down 9.3%.

Despite having a gloomy near-term outlook, there are few stocks in the industry worth watching. Before we present those stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock-market performance and valuation picture.

Industry Beats Sector and S&P 500

The Zacks Instruments – Scientific industry has outperformed the broader Zacks Computer and Technology sector and the S&P 500 composite over the past year.

The industry has declined 6.8% over this period compared with the S&P 500’s fall of 14.2% and the broader sector’s slip of 16.4%.

Industry's Current Valuation

On the basis of the forward 12-month P/E, which is a commonly used multiple for valuing scientific instrument stocks, we see that the industry is currently trading at 27.19X compared with the S&P 500’s 17.83X and the Zacks Computer and Technology sector’s 22.68X.

Over the last five years, the industry has traded as high as 36.31X, as low as 21.24X and at the median of 25.63X.

2 Scientific Instruments Providers to Watch

Mettler-Toledo: The Zacks Rank #3 (Hold) company is benefiting from the solid momentum across its laboratory and industrial segments.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Mettler-Toledo’s strengthening presence in the Americas, Europe, Asia and the Rest of the World is a positive. Portfolio strength, cost-cutting efforts, robust sales and marketing strategies, benefits from investments in Spinnaker sales, and field resources are contributing well. A strong core industrial business is encouraging. Solid demand across pharmaceutical and life science markets is another tailwind.

Shares of this Polaris Parkway, Columbus, OH-based company have gained 4.6% in the past year. The Zacks Consensus Estimate for Mettler-Toledo’s current-year earnings has declined 0.7% to $44 per share in the past 30 days.

Waters: The Milford, MA-based company is an analytical instrument manufacturer. It offers practical and sustainable products for laboratory-dependent organizations.

Waters is gaining from growth in its top global pharma accounts. Solid momentum across new product lines like BioAccord and Cyclic IMS is a positive. The company’s strengthening presence in the industrial and pharmaceutical end markets is a tailwind.

Waters currently has a Zacks Rank #3. The Zacks Consensus Estimate for Waters’ current-year earnings has declined by a penny to $12.67 per share over the past 30 days. WAT’s shares have moved down 8.5% in the past year.

Why Haven’t You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.

See Stocks Free >>

Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch/

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Waters Corporation (WAT) : Free Stock Analysis Report

Mettler-Toledo International, Inc. (MTD) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research